Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 kappa monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.Reslizumab improves lung function, induces a decrease in eosinophil production and maturation, and may be used in the study of asthma.
Purity:
98.10%
CAS Number:
[241473-69-8]
Target:
Interleukin|||IL Receptor
T12706
* VAT and and shipping costs not included. Errors and price changes excepted